NTLA
Intellia Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
Analysts project Intellia Therapeutics will report Q2 2026 revenue of $13.4 million and a net loss of $0.80 per share, with the current stock price of $10.68...
